Investor Presentation

Download our latest investor presentation.

Download

Press Releases

February 6, 2020 • 8:11 AM EST

Amarantus Announces Subsidiary MANF Therapeutics Enters Into Material Transfer Agreement with Dyadic International

February 4, 2020 • 9:54 AM EST

Amarantus Releases Letter to Shareholders

January 30, 2020 • 9:05 AM EST

Amarantus Acquires Majority Interest in CBD Wellness Company Hempori

January 2, 2020 • 8:14 AM EST

Amarantus Completes Sublicense of ESS, MANF and PhenoGuard to Emerald Organic Products